Skip to content

Pulmonary Rehabilitation and Smoking

Effectiveness of Pulmonary Rehabilitation in Smoker Patients With COPD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03671187
Enrollment
31
Registered
2018-09-14
Start date
2015-01-31
Completion date
2018-08-31
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rehabilitation; Tobacco Use, Smoking

Brief summary

Pulmonary rehabilitation (PR) is known to reduce dyspnea, increase exercise capacity, reduce psychological symptoms and improve quality of life in COPD patients. Some patients continue to smoke despite their illness. Smoking does not create a contraindication to PR. There is insufficient evidence on the effectiveness of PR programs in smoking COPD patients. The purpose of this study, PR completed the program to determine the effectiveness of PR smoker COPD patients.

Detailed description

Pulmonary rehabilitation (PR) is known to reduce dyspnea, increase exercise capacity, reduce psychological symptoms and improve quality of life in COPD patients. Some patients continue to smoke despite their illness. Smoking does not create a contraindication to PR. There is insufficient evidence on the effectiveness of PR programs in smoking COPD patients. The purpose of this study, PR completed the program to determine the effectiveness of PR smoker COPD patients. People who have completed the PR program, smoking and not smoking will be included into the study. Data of carbon monoxide diffusion test, body plethysmography, 6-min walk test, blood gas analysis, mMRC dyspnea scale, hospital anxiety depression scale, SGRQ and SF-36 quality of life questionnaire performed before and after the program will be analyzed.

Interventions

OTHERExercise

8 week exercise program

Sponsors

Izmir Katip Celebi University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* COPD patients completed 8 PR program

Exclusion criteria

* Never smoked patients * Participated PR program in last year

Design outcomes

Primary

MeasureTime frameDescription
Six minute walk test6 minutesIt was performed in a 30-meter long corridor in accordance with American Thoracic

Secondary

MeasureTime frameDescription
Pulmonary Function Test20 minutesIt was used for assessment of lung functions
Dyspnea Severity5 minuesMMRC Dyspnea Scale (0: no dyspnea, 4: very severe dyspnea), It was used for dyspnea that patients felt during their daily activities.
St. George Disease Related Quality of Life Scale20 minutesA disease-specific quality of life scale (Max. score:100, lower score means better quality of life level)
Short Form-36 Quality of Life Survey25 minutesA health related quality of life scale, Short Form-36 Quality of Life Survey (Max. score:100, higher score means better quality of life level)
Hospital Anxiety and Depression Inventory20 minutesIt was used for assessment of anxiety and depression

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026